AOD-9604: a growth hormone fragment and metabolism

AOD-9604 is one of those peptides that sound simple: “a growth hormone fragment that acts only on fat”. The reality is more complicated. The fragment is indeed part of the hormone, but that does not mean it has the same effects or that it is clinically effective.

What is AOD-9604?

AOD-9604 is a synthetic fragment of human growth hormone (hGH) comprising amino acids 176–191, 16 amino acids long. Its structure was designed to preserve the putative lipolytic region, but not the regions associated with growth and other systemic effects.

It is important to understand that the fragment is not the same as the whole hormone. Removing part of the sequence changes binding, stability and the biological response.

What is lipolysis?

Lipolysis is the breakdown of triglycerides in fat cells into free fatty acids and glycerol. It is a normal metabolic process regulated by hormones, the nervous system and the body’s energy state.

Increased lipolysis does not in itself mean that body mass will decrease. Fatty acids can be taken up and stored again, and the body can compensate through appetite or reduced energy expenditure. It is therefore necessary to distinguish between mechanism and clinical outcome.

What do studies show?

Preclinical research has reported effects on lipolysis and fatty acid metabolism. Some studies in humans have examined safety and pharmacokinetics, and others the effect on body composition.

The results are mixed. Randomised studies have not confirmed a consistent, clinically meaningful reduction in body mass. Possible reasons:

1. differences in dose and duration;
2. differences in the measurement of body composition;
3. metabolic compensation;
4. publication bias;
5. the difference between a short-term signal and a long-term outcome.

AOD-9604 is not growth hormone

This is a key difference. Growth hormone affects growth, metabolism, bone density and many other processes. A fragment containing only the lipolytic region is supposed to act more selectively — but precisely for that reason its effect is not the same as that of the hormone.

The fragment is also not a steroid. It is a peptide that does not act through the androgen receptor. Read more about the difference in the article peptides and steroids.

Safety and regulation

AOD-9604 is not an approved medicine. Long-term safety in humans has not been established. In sport, growth hormone fragments may be prohibited; check the rules in force.

Any use in humans without approval and professional supervision carries unknown risk. Our vial is intended for laboratory research use.

Quality

The description declares a purity of ≥ 98 % (HPLC). For short peptides, correct identification and the absence of related fragments are particularly important. Mass spectrometry helps confirm that the molecule is not a similar but incorrect one.

Conclusion

AOD-9604 is an interesting example of how a promising preclinical hypothesis can fail to meet expectations in clinical trials. It remains a research compound, not a proven means of changing body composition.